Renew Research, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type (NCT03721705) | Renew Research, LLC | 2018-11-12 |
Track Renew Research, LLC automatically
Every clearance here is in the API, with alerts when new ones post.